BIOMAT Database Logo BIOMAT Database Logo

Synthesis and biological evaluation of some thiazole derivatives as new cholinesterase inhibitors. 2013

Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Department of Pharmaceutical Chemistry, Anadolu University, Faculty of Pharmacy, Eskişehir, Turkey.

In the present study, some thiazole derivatives were synthesized via the ring closure reaction of 1-[2-(2-oxobenzo[d]thiazol-3(2H)-yl)acetyl]thiosemicarbazide with various phenacyl bromides. The chemical structures of the compounds were elucidated by (1)H NMR, (13)C NMR and mass spectral data and elemental analyses. Each derivative was evaluated for its ability to inhibit acetylcholinesterase (AChE) and butyrylcholinesterase (BuChE) using a modification of Ellman's spectrophotometric method. The compounds were also investigated for their cytotoxic properties using MTT assay. The most potent AChE inhibitor was found as compound 4e (IC(50) = 25.5 ± 2.12 µg/mL) followed by compounds 4i (IC(50) = 38.50 ± 2.12 µg/mL), 4c (IC(50) = 58.42 ± 3.14 µg/mL) and 4g (IC(50) = 68 ± 2.12 µg/mL) when compared with eserine (IC(50) = 0.025 ± 0.01 µg/mL). Effective compounds on AChE exhibited weak inhibition on BuChE (IC(50) > 80 µg/mL). MTT assay indicated that the cytotoxic dose (IC(50) = 71.67 ± 7.63 µg/mL) of compound 4e was higher than its effective dose.

UI MeSH Term Description Entries
D009682 Magnetic Resonance Spectroscopy Spectroscopic method of measuring the magnetic moment of elementary particles such as atomic nuclei, protons or electrons. It is employed in clinical applications such as NMR Tomography (MAGNETIC RESONANCE IMAGING). In Vivo NMR Spectroscopy,MR Spectroscopy,Magnetic Resonance,NMR Spectroscopy,NMR Spectroscopy, In Vivo,Nuclear Magnetic Resonance,Spectroscopy, Magnetic Resonance,Spectroscopy, NMR,Spectroscopy, Nuclear Magnetic Resonance,Magnetic Resonance Spectroscopies,Magnetic Resonance, Nuclear,NMR Spectroscopies,Resonance Spectroscopy, Magnetic,Resonance, Magnetic,Resonance, Nuclear Magnetic,Spectroscopies, NMR,Spectroscopy, MR
D002091 Butyrylcholinesterase An aspect of cholinesterase (EC 3.1.1.8). Pseudocholinesterase,Benzoylcholinesterase,Butyrylthiocholinesterase
D002800 Cholinesterase Inhibitors Drugs that inhibit cholinesterases. The neurotransmitter ACETYLCHOLINE is rapidly hydrolyzed, and thereby inactivated, by cholinesterases. When cholinesterases are inhibited, the action of endogenously released acetylcholine at cholinergic synapses is potentiated. Cholinesterase inhibitors are widely used clinically for their potentiation of cholinergic inputs to the gastrointestinal tract and urinary bladder, the eye, and skeletal muscles; they are also used for their effects on the heart and the central nervous system. Acetylcholinesterase Inhibitor,Acetylcholinesterase Inhibitors,Anti-Cholinesterase,Anticholinesterase,Anticholinesterase Agent,Anticholinesterase Agents,Anticholinesterase Drug,Cholinesterase Inhibitor,Anti-Cholinesterases,Anticholinesterase Drugs,Anticholinesterases,Cholinesterase Inhibitors, Irreversible,Cholinesterase Inhibitors, Reversible,Agent, Anticholinesterase,Agents, Anticholinesterase,Anti Cholinesterase,Anti Cholinesterases,Drug, Anticholinesterase,Drugs, Anticholinesterase,Inhibitor, Acetylcholinesterase,Inhibitor, Cholinesterase,Inhibitors, Acetylcholinesterase,Inhibitors, Cholinesterase,Inhibitors, Irreversible Cholinesterase,Inhibitors, Reversible Cholinesterase,Irreversible Cholinesterase Inhibitors,Reversible Cholinesterase Inhibitors
D004305 Dose-Response Relationship, Drug The relationship between the dose of an administered drug and the response of the organism to the drug. Dose Response Relationship, Drug,Dose-Response Relationships, Drug,Drug Dose-Response Relationship,Drug Dose-Response Relationships,Relationship, Drug Dose-Response,Relationships, Drug Dose-Response
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D000110 Acetylcholinesterase An enzyme that catalyzes the hydrolysis of ACETYLCHOLINE to CHOLINE and acetate. In the CNS, this enzyme plays a role in the function of peripheral neuromuscular junctions. EC 3.1.1.7. Acetylcholine Hydrolase,Acetylthiocholinesterase,Hydrolase, Acetylcholine
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships
D013844 Thiazoles Heterocyclic compounds where the ring system is composed of three CARBON atoms, a SULFUR and NITROGEN atoms. Thiazole
D015394 Molecular Structure The location of the atoms, groups or ions relative to one another in a molecule, as well as the number, type and location of covalent bonds. Structure, Molecular,Molecular Structures,Structures, Molecular

Related Publications

Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Synthesis and biological evaluation of thiazole derivatives as LbSOD inhibitors.
December 2019, Journal of enzyme inhibition and medicinal chemistry,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Synthesis and biological evaluation of some pyrazoline derivatives bearing a dithiocarbamate moiety as new cholinesterase inhibitors.
March 2013, Archiv der Pharmazie,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Synthesis and biological evaluation of thiazole derivatives as novel USP7 inhibitors.
February 2017, Bioorganic & medicinal chemistry letters,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Synthesis and Biological Evaluation of Thiazole-Based Derivatives as Potential Acetylcholinesterase Inhibitors.
July 2021, ACS omega,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
September 2014, Bioorganic & medicinal chemistry letters,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Design, synthesis and biological evaluation of metronidazole-thiazole derivatives as antibacterial inhibitors.
November 2014, Bioorganic & medicinal chemistry letters,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors.
December 2009, Bioorganic & medicinal chemistry letters,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Arylaminopropanone Derivatives as Potential Cholinesterase Inhibitors: Synthesis, Docking Study and Biological Evaluation.
April 2020, Molecules (Basel, Switzerland),
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Design, Synthesis and Biological Evaluation of New Imidazo[2,1-b]Thiazole Derivatives as Selective COX-2 Inhibitors.
January 2018, Iranian journal of pharmaceutical research : IJPR,
Gülhan Turan-Zitouni, and Ahmet Ozdemir, and Zafer Asim Kaplancikli, and Mehlika Dilek Altintop, and Halide Edip Temel, and Gülşen Akalın Çiftçi
Synthesis and biological evaluation of some novel thiazole substituted benzotriazole derivatives.
May 2012, Bioorganic & medicinal chemistry letters,
Copied contents to your clipboard!